All Stories

  1. MDR bacteria could be treated with colistin in combination with other antimicrobials

    Article • Infection and Drug Resistance, July 2019, Dove Medical Press

    Jordi Hernandez-Borrell, Miguel Vinas, Ester Fusté

  2. Determination of the spatiotemporal dependence of Pseudomonas aeruginosa biofilm viability after treatment with NLC-colistin

    Article • International Journal of Nanomedicine, June 2017, Dove Medical Press

    Miguel Vinas

  3. An overview of antimicrobial peptides and the latest advances in their development

    Article • Expert Opinion on Biological Therapy, April 2017, Taylor & Francis

    Miguel Vinas, Ester Fusté

  4. Clinical laser treatment of toenail onychomycoses

    Article • Lasers in Medical Science, April 2017, Springer Science + Business Media

    Miguel Vinas

  5. Transcriptomics as a tool to discover new antibacterial targets

    Article • Biotechnology Letters, March 2017, Springer Science + Business Media

    Miguel Vinas

  6. Bacteremia Associated with Oral Surgery: A Review

    Article • Journal of Evidence Based Dental Practice, December 2016, Elsevier

    Miguel Vinas

  7. Human papillomaviruses genotyping in plantar warts

    Article • Journal of Medical Virology, October 2016, Wiley

    Miguel Vinas

  8. Synergistic Antipseudomonal Effects of Synthetic Peptide AMP38 and Carbapenems

    Article • Molecules, September 2016, MDPI AG

    Miguel Vinas

  9. Draft Genome Sequence of Dietzia maris DSM 43672, a Gram-Positive Bacterium of the Mycolata Group

    Article • Genome Announcements, June 2016, ASM Journals

    Dr Daniel Pletzer, Miguel Vinas

  10. New Weapons to Control Bacterial Growth

    Article • January 2016, Springer Science + Business Media

    Miguel Vinas

  11. Introductory Chapter

    Article • January 2016, Springer Science + Business Media

    Miguel Vinas

  12. Bacterial Predation: Natural Guns to Control Infection

    Article • January 2016, Springer Science + Business Media

    Miguel Vinas

  13. The Biological Fight Against Pathogenic Bacteria and Protozoa

    Article • January 2016, Springer Science + Business Media

    Miguel Vinas

  14. Virus en Endodoncia

    Article • International journal of odontostomatology, September 2014, SciELO Comision Nacional de Investigacion Cientifica Y Tecnologica (CONICYT)

    Miguel Vinas

  15. Effect of nonsurgical periodontal treatment on glycosylated hemoglobin in diabetic patients: a systematic review

    Article • Odontology, July 2014, Springer Science + Business Media

    Miguel Vinas

  16. Perspectives in the Research on Antimicrobial Peptides

    Article • October 2013, Springer Science + Business Media

    Miguel Vinas

  17. Comparison of antibiotic susceptibility of old and current Serratia

    Article • Future Microbiology, June 2012, Future Medicine

    Miguel Vinas

  18. Fragment of the Ancient RbcL Gene from the Miocene

    Article • Scholarly Research Exchange, January 2008, Hindawi Publishing Corporation

    Miguel Vinas

  19. Molecular and functional characterisation of the Serratia marcescens outer membrane protein Omp1

    Article • Biophysical Chemistry, May 2004, Elsevier

    Miguel Vinas

  20. Relationship between clinical and environmental isolates of Pseudomonas aeruginosa in a hospital setting

    Article • Archives of Medical Research, May 2004, Elsevier

    Miguel Vinas

  21. Bacterial membrane injuries induced by lactacin F and nisin

    Article • International Microbiology, May 2002, Springer Science + Business Media

    Miguel Vinas

  22. Mechanisms other than penicillin-binding protein-2 alterations may contribute to moderate penicillin resistance in Neisseria meningitidis

    Article • International Journal of Antimicrobial Agents, August 2001, Elsevier

    Miguel Vinas

  23. Role of the outer membrane in the accumulation of quinolones bySerratia marcescens

    Article • Canadian Journal of Microbiology, August 2000, Canadian Science Publishing

    Miguel Vinas

  24. Transfer of Penicillin Resistance BetweenNeisseriaein Microcosm

    Article • Microbial Drug Resistance, June 2000, Mary Ann Liebert Inc

    Miguel Vinas